Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking

Neuropsychopharmacology

Volumn 37, Issue 13, 2012, Pages 2837-2845

  Achat Mendes, Cindy ^a   Nic Dhonnchadha, Bríd Á ^b   Platt, Donna M ^a   Kantak, Kathleen M ^b   Spealman, Roger D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

cocaine self administration; extinction training; glycine transporter 1 inhibitor; relapse

Indexed keywords

COCAINE; GLYCINE TRANSPORTER 1; ORG 24598; PROTEIN INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SQUIRREL MONKEY; VISUAL IMPAIRMENT; VISUAL STIMULATION; WISTAR RAT;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; EXTINCTION, PSYCHOLOGICAL; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; RATS; RATS, WISTAR; SAIMIRI; SELF ADMINISTRATION;

EID: 84869084652     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.155     Document Type: Article

References (38)

1. Achat-Mendes C, Grundt P, Cao J, Platt DM, Newman AH, Spealman RD (2010). Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys. J Pharmacol Exp Ther 334: 556-565.
2. Atkinson BN, Bell SC, De Vivo M, Kowalski LR, Lechner SM, Ognyanov VI et al (2001). ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol Pharmacol 60: 1414-1420.
3. Brown A, Carlyle I, Clark J, Hamilton W, Gibson S, McGarry G et al (2001). Discovery and SAR of Org24598-a selective glycine uptake inhibitor. Bioorg Med Chem Lett 11: 2007-2009.
4. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ (2007). Consolidation of fear extinction requires NMDA receptordependent bursting in the ventromedial prefrontal cortex. Neuron 53: 871-880.
5. Chen L, Mulhauser M, Yang CR (2003). Glycine transporter-1 blockade potentiates NMDA mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J Neurophysiol 89: 691.
6. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18.
7. Cleva RM, Gass JT, Widholm JJ, Olive MF (2010). Glutamatergic targets for enhancing extinction learning in drug addiction. Curr Neuropharmacol 8: 394-408.
8. Dubroqua S, Singer P, Boison D, Feldon J, Möhler H, Yee BK (2010). Impacts of forebrain neuronal glycine transporter 1 disruption in the senescent brain: evidence for age-dependent phenotypes in Pavlovian learning. Behav Neurosci 124: 839-850.
9. Feltenstein MW, See RE (2007). NMDA receptor blockade in the basolateral amygdala disrupts consolidation of stimulus-reward memory and extinction learning during reinstatement of cocaine-seeking in an animal model of relapse. Neurobiol Learn Mem 88: 435-444.
10. Goldstein RZ, Tomasi D, Alia-Klein N, Honorio Carrillo J, Maloney T, Woicik PA et al (2009). Dopaminergic response to drug words in cocaine addiction. J Neurosci 29: 6001-6006.
11. Hofmann SG (2007). Enhancing exposure-based therapy from a translational research perspective. Behav Res Ther 45: 1987-2001.
12. Inda MC, Delgado-García JM, Carrión AM (2005). Acquisition, consolidation, reconsolidation, and extinction of eyelid conditioning responses require de novo protein synthesis. J Neurosci 25: 2070-2080.
13. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F et al (2001). Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58: 334-341.
14. Kinney GG, Sur C, Burno M, Mallorga PJ, Williams JB, Figueroa DJ et al (2003). The glycine transporter type 1 inhibitor N-[3-(40-fluorophenyl)-3-(40- phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23: 7586-7591.
15. Le Pen G, Kew J, Alberati D, Borroni E, Heitz MP, Moreau JL (2003). Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biol Psychiatry 54: 1162-1170.
16. Lidö HH, Marston H, Ericson M, Söderpalm B (2011). The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598. Addict Biol (e-pub ahead of print 28 September 2011) doi:10.1111/j.1369-1600.2011.00367.
17. Liem-Moolenaar M, Zoethout RW, de Boer P, Schmidt M, de Kam ML, Cohen AF et al (2010). The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects. J Psychopharmacol 24: 1671-1679.
18. Loftis JM, Janowsky A (2002). Cocaine treatment- and withdrawalinduced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit. Psychopharmacology (Berl) 64: 349-359.
19. Mallorga PJ, Williams JB, Jacobson M, Marques R, Chaudhary A, Conn PJ et al (2003). Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(40-fluorophenyl)-3-(40phenylphenoxy)propyl])sarcosine. Neuropharmacology 45: 585-593.
20. Myers KM, Carlezon WA Jr, Davis M (2011). Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36: 274-293.
21. NicDhonnchadha BÁ, Pinard E, Alberati D, Wettstein JG, Spealman RD, Kantak KM (2011). Inhibiting glycine transporter- 1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior. Drug Alcohol Depend 122: 119-126.
22. Nic Dhonnchadha BÁ., Szalay JJ, Achat-Mendes C, Platt DM, Otto MW, Spealman RD et al (2010). D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology 35: 357-367.
23. Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P (2011). Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology 61: 262-267.
24. O'Malley SS, Sinha R, Grilo CM, Capone C, Farren CK, McKee SA et al (2007). Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial. Alcohol Clin Exp Res 31: 625-634.
25. Platt DM, Carey G, Spealman RD (2011). Models of neurological disease (substance abuse): self-administration in monkeys. Curr Protoc Pharmacol; Chapter 10:Unit 10.5.
26. Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56-72.
27. Robinson T, Berridge KC (2001). Incentive-sensitization and addiction. Addiction 96: 106-114.
28. Self DW, Choi KH, Simmons D, Walker JR, Smagula CS (2004). Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem 11: 648-657.
29. Singer P, Feldon J, Yee BK (2009). The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice. Psychopharmacology (Berl) 202: 371-384.
30. Sinha R (2009). Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14: 84-98.
31. Sotres-Bayon F, Bush DE, LeDoux JE (2007). Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 32: 1929-1940.
32. Torregrossa MM, Sanchez H, Taylor JR (2010). D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens. J Neurosci 30: 10526-10533.
33. Turchan J, Maj M, Przewlocka B (2003). The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system. Drug Alcohol Depend 72: 193-196.
34. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR et al (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
35. Wallace TL, Ballard TM, Pouzet B, Riedel WJ, Wettstein JG (2011). Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacol Biochem Behav 99: 130-145.
36. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A et al (2006). Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31: 2716-2727.
37. Yamaguchi M, Suzuki T, Abe S, Hori T, Kurita H, Asada T et al (2002). Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A-C) mRNAs in rat brain. Synapse 46: 157-169.
38. Zweifel LS, Argilli E, Bonci A, Palmiter RD (2008). Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 59: 486-496.